Shama Afzal, PHARMD
Pharmacist in Manteca, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 291,043 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Shama Afzal, PHARMD filed 1,162 Medicare Part D claims in 2023 as a Pharmacist in Manteca, California, prescribing 98% generic.
- 1K
- Part D claims, 2023
- 98%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Shama Afzal, PHARMD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,162 Top 23% higher than 77% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Shama Afzal, PHARMD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Pharmacist compares to other specialties among California providers
Pharmacist ranks #5 among California's specialties (3.5% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Pharmacist; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Shama Afzal, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 1721 W YOSEMITE AVE, Manteca, CA, 95337, with a listed phone of (209) 824-5061. NPI 1104350743 was issued on 04/19/2017.
Medicare Part D records for calendar year 2023 show 1,162 prescription claims written by this provider, covering 348 Medicare beneficiaries and totaling roughly $37K in drug spend, split 1% brand-name and 98% generic by claim count, with an opioid prescribing rate of 18.0%.
Pharmacist is a high-volume specialty nationwide, with 291,043 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1104350743 |
|---|---|
| Specialty | Pharmacist |
| Credentials | PHARMD |
| Gender | Female |
| NPI Issued | 04/19/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Shama Afzal, PHARMD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1104350743 is the unique 10-digit identifier CMS uses to link Afzal across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Shama Afzal, PHARMD. To verify Shama Afzal, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
1% brand-name claims vs 98% generic, on 1,162 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,675
- Total Day Supply
- 46,275
- Brand vs Generic
- 1% brand / 98% generic
- Brand Drug Cost
- $5K
- Generic Drug Cost
- $32K
- Opioid Claims
- 209 (18.0% rate)
Patient Demographics
- Average Patient Age
- 70.0 years
- Avg HCC Risk Score
- 1.41
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 71, 65-74: 170, 75-84: 92, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Shama Afzal, PHARMD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pregabalin
Pregabalin
217 claims
- Duloxetine Hcl
Duloxetine Hcl
197 claims
- Diclofenac Sodium
Diclofenac Sodium
144 claims
- Gabapentin
Gabapentin
101 claims
- Hydrocodone-Acetam… 61
Hydrocodone-Acetaminophen
61 claims
- Tizanidine Hcl 58
Tizanidine Hcl
58 claims
- Morphine Sulfate Er 55
Morphine Sulfate Er
55 claims
- Methocarbamol 49
Methocarbamol
49 claims
| Drug | Claims |
|---|---|
| Pregabalin | 217 |
| Duloxetine Hcl | 197 |
| Diclofenac Sodium | 144 |
| Gabapentin | 101 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 |
| Tizanidine Hcl | 58 |
| Morphine Sulfate Er Morphine Sulfate | 55 |
| Methocarbamol | 49 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 44 |
| Oxycodone Hcl | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How Shama Afzal, PHARMD fits within the Pharmacist landscape nationally.
Shama Afzal, PHARMD's 1,162 claims are above the specialty average of 135.
Nearby Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Afzal.
Compare Pharmacist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pharmacist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Shama Afzal, PHARMD's specialty? ▼
How much does Shama Afzal, PHARMD prescribe under Medicare Part D? ▼
Where is Shama Afzal, PHARMD located? ▼
What is Shama Afzal, PHARMD's NPI number? ▼
Does Shama Afzal, PHARMD prescribe more brand-name or generic drugs? ▼
Does Shama Afzal, PHARMD prescribe opioids? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does Shama Afzal, PHARMD prescribe most often? ▼
Does Shama Afzal, PHARMD accept Medicare? ▼
How can I verify Shama Afzal, PHARMD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.